Literature DB >> 4834800

Use of progestational agents in endometrial adenocarcinoma.

J C Rozier, P B Underwood.   

Abstract

Entities:  

Keywords:  Antimetabolites; Cancer; Clinical Research; Contraception; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--therapeutic use; Diseases; Endometrial Cancer; Evaluation; Family Planning; Medroxyprogesterone Acetate--therapeutic use; Megestrol Acetate--therapeutic use; Neoplasms; Research Methodology

Mesh：

Substances：

Year:  1974        PMID： 4834800

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  3 in total

1.  Depo-Provera--ethical issues in its testing and distribution.

Authors:  M Potts; J M Paxman
Journal:  J Med Ethics       Date:  1984-03       Impact factor: 2.903

Review 2.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

3.  [Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma (author's transl)].

Authors:  K Pollow; E Boquoi
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.